SLC2A1 and irritable bowel syndrome: Previously, in an animal model of irritable bowel syndrome (IBS), we observed that KD affected glucose metabolism and intestinal membrane permeability, with an overexpression of the glucose transporter GLUT1 and tight junction proteins [13].